Hepatitis C virus (HCV) diagnosis via microfluidics

Area of Science:

• Hepatology
• Virology
• Biomedical Engineering

Background:

• Hepatitis C virus (HCV) infection poses a significant threat to liver health, necessitating accurate and timely diagnosis.
• Current diagnostic methods include antibody, antigen, and RNA detection, with immunoassays playing a key role.
• There is a growing need for point-of-care tests (POCT) to enhance accessibility and efficiency in HCV diagnosis.

Purpose of the Study:

• To review and assess the potential of various microfluidic detection techniques for HCV diagnosis.
• To evaluate current confirmatory approaches and market players in HCV chip-based diagnosis.
• To present future perspectives for improving HCV diagnosis through advanced technologies.

Main Methods:

• Literature review of microfluidic detection techniques for HCV.
• Assessment of current diagnostic strategies and market landscape for HCV POCT.
• Analysis of future trends in HCV diagnosis.

Main Results:

• Microfluidic technologies show promise for sensitive, specific, and rapid HCV detection.
• Several market players are actively developing and commercializing chip-based HCV diagnostic solutions.
• Molecular assays offer high precision, but alternative strategies are needed for broader HCV diagnosis.

Conclusions:

• Microfluidic-based POCT can significantly enhance HCV diagnosis, enabling timely treatment and risk management.
• Continued development and strategic selection of POCT are critical for optimal patient outcomes.
• Future innovations in microfluidics and chip-based diagnostics will further simplify and improve HCV detection.